BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 5477489)

  • 1. The effect of propranolol on circulatory hemodynamics of patients with coronary heart failure in the light of polycardiographic examination.
    Mazurowa A; Tracz W
    Pol Med J; 1970; 9(4):827-34. PubMed ID: 5477489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic changes following blockade of the beta-receptors in healthy persons and in patients with coronary heart disease. Comparison between Trasicor and Inderal].
    Bürgin D
    Schweiz Med Wochenschr; 1968 Jun; 98(25):940-5. PubMed ID: 5699197
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamic changes in patients with coronary heart disease after beta-adrenergic blockade with propranolol.
    Bürgin D
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):365-70. PubMed ID: 4395489
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic studies on hypertension. II. Effects of isoproterenol, propranolol, noradrenaline and phentolamine on the hemodynamics in essential hypertension.
    Tsuchiya M
    Jpn Circ J; 1972 Mar; 36(3):275-88. PubMed ID: 5068095
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac effects of isoproterenol during graded myocardial ischemia.
    Lekven J; Kjekshus JK; Mjös OD
    Scand J Clin Lab Invest; 1974 Apr; 33(2):161-71. PubMed ID: 4850884
    [No Abstract]   [Full Text] [Related]  

  • 6. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
    Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
    Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation].
    Goloshchapov OA; Pribylova NN; Kotova LN; Nozhnova LP
    Ter Arkh; 1986; 58(11):29-32. PubMed ID: 3824185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of N-n-propyl-ajmalinebitartrate (NPAB) on left ventricular dynamics].
    Klein WW; Pavek P; Brandt D
    Arzneimittelforschung; 1974 Dec; 24(12):2048-50. PubMed ID: 4480363
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in hemodynamics under the effect of two beta sympathicolytics of various pharmacodynamic principle].
    Lang E; Holtmann W
    Arzneimittelforschung; 1974 Sep; 24(9):1330-5. PubMed ID: 4479799
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurogenic maintenance of peripheral resistance in borderline hypertension.
    Julius S; Esler M; Randall OS; Ellis C
    Acta Physiol Lat Am; 1974; 24(5):425-31. PubMed ID: 4467668
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of clinical testing of carbochromen in chronic coronary insufficiency].
    Schvacabaja IK; Mjasnikov LA; Metelica VI; Grigorjanc RA
    Arzneimittelforschung; 1970 Mar; 20():449-51. PubMed ID: 4916579
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular response in hyperthyroidism. The influence of adrenergic-receptor blockade.
    Pietras RJ; Real MA; Poticha GS; Bronsky D; Waldstein SS
    Arch Intern Med; 1972 Mar; 129(3):426-9. PubMed ID: 4401571
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of nitroglycerin, propranolol, and their combination in coronary heart disease.
    Wiener L; Dwyer EM; Cox JW
    Circulation; 1969 May; 39(5):623-32. PubMed ID: 4977790
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic effect of a beta-receptor blocking agent (LB-46) on hemodynamics].
    Köhler M
    Z Kreislaufforsch; 1970 Aug; 59(8):708-19. PubMed ID: 5513291
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure and vascular design in renal hypertension in rats after prolonged propranolol treatment.
    Lundgren Y
    Acta Physiol Scand; 1974 Jul; 91(3):409-16. PubMed ID: 4846333
    [No Abstract]   [Full Text] [Related]  

  • 19. Sympathetic control of coronary and systemic hemodynamics in emotional stress in the conscious dog.
    Bergamaschi M; Shanks RG; Mandelli V
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():399-407. PubMed ID: 4157080
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulatory effects of oxprenolol, a new beta-adrenergic blocking agent.
    Reale A; Motolese M; Imhof P
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):288-93. PubMed ID: 4394124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.